Literature DB >> 27107787

The IASLC Lung Cancer Staging Project: Proposals for Coding T Categories for Subsolid Nodules and Assessment of Tumor Size in Part-Solid Tumors in the Forthcoming Eighth Edition of the TNM Classification of Lung Cancer.

William D Travis1, Hisao Asamura2, Alexander A Bankier3, Mary Beth Beasley4, Frank Detterbeck5, Douglas B Flieder6, Jin Mo Goo7, Heber MacMahon8, David Naidich9, Andrew G Nicholson10, Charles A Powell11, Mathias Prokop12, Ramón Rami-Porta13, Valerie Rusch14, Paul van Schil15, Yasushi Yatabe16.   

Abstract

This article proposes codes for the primary tumor categories of adenocarcinoma in situ (AIS) and minimally invasive adenocarcinoma (MIA) and a uniform way to measure tumor size in part-solid tumors for the eighth edition of the tumor, node, and metastasis classification of lung cancer. In 2011, new entities of AIS, MIA, and lepidic predominant adenocarcinoma were defined, and they were later incorporated into the 2015 World Health Organization classification of lung cancer. To fit these entities into the T component of the staging system, the Tis category is proposed for AIS, with Tis (AIS) specified if it is to be distinguished from squamous cell carcinoma in situ (SCIS), which is to be designated Tis (SCIS). We also propose that MIA be classified as T1mi. Furthermore, the use of the invasive size for T descriptor size follows a recommendation made in three editions of the Union for International Cancer Control tumor, node, and metastasis supplement since 2003. For tumor size, the greatest dimension should be reported both clinically and pathologically. In nonmucinous lung adenocarcinomas, the computed tomography (CT) findings of ground glass versus solid opacities tend to correspond respectively to lepidic versus invasive patterns seen pathologically. However, this correlation is not absolute; so when CT features suggest nonmucinous AIS, MIA, and lepidic predominant adenocarcinoma, the suspected diagnosis and clinical staging should be regarded as a preliminary assessment that is subject to revision after pathologic evaluation of resected specimens. The ability to predict invasive versus noninvasive size on the basis of solid versus ground glass components is not applicable to mucinous AIS, MIA, or invasive mucinous adenocarcinomas because they generally show solid nodules or consolidation on CT.
Copyright © 2016 International Association for the Study of Lung Cancer. All rights reserved.

Entities:  

Keywords:  Adenocarcinoma in situ; Lepidic predominant adenocarcinoma; Lung cancer; Lung cancer staging; Minimally invasive adenocarcinoma; TNM classification; Tumor size

Mesh:

Year:  2016        PMID: 27107787     DOI: 10.1016/j.jtho.2016.03.025

Source DB:  PubMed          Journal:  J Thorac Oncol        ISSN: 1556-0864            Impact factor:   15.609


  153 in total

1.  Pathologic Assessment After Neoadjuvant Chemotherapy for NSCLC: Importance and Implications of Distinguishing Adenocarcinoma From Squamous Cell Carcinoma.

Authors:  Yang Qu; Katsura Emoto; Takashi Eguchi; Rania G Aly; Hua Zheng; Jamie E Chaft; Kay See Tan; David R Jones; Mark G Kris; Prasad S Adusumilli; William D Travis
Journal:  J Thorac Oncol       Date:  2018-11-29       Impact factor: 15.609

Review 2.  The 8th lung cancer TNM classification and clinical staging system: review of the changes and clinical implications.

Authors:  Wanyin Lim; Carole A Ridge; Andrew G Nicholson; Saeed Mirsadraee
Journal:  Quant Imaging Med Surg       Date:  2018-08

Review 3.  [The new TNM classification for lung tumors : Changes and the assessment of multiple tumor foci].

Authors:  A Harms; M Kriegsmann; L Fink; F Länger; A Warth
Journal:  Pathologe       Date:  2017-02       Impact factor: 1.011

4.  Effect of CT window settings on size measurements of the solid component in subsolid nodules: evaluation of prediction efficacy of the degree of pathological malignancy in lung adenocarcinoma.

Authors:  Qiong Li; Ya-Feng Gu; Li Fan; Qing-Chu Li; Yi Xiao; Shi-Yuan Liu
Journal:  Br J Radiol       Date:  2018-06-06       Impact factor: 3.039

5.  Recommendations from the European Society of Thoracic Surgeons (ESTS) regarding computed tomography screening for lung cancer in Europe.

Authors:  Jesper Holst Pedersen; Witold Rzyman; Giulia Veronesi; Thomas A D'Amico; Paul Van Schil; Laureano Molins; Gilbert Massard; Gaetano Rocco
Journal:  Eur J Cardiothorac Surg       Date:  2017-03-01       Impact factor: 4.191

6.  How to deal with subcentimeter lung cancer: a moving target!

Authors:  Paul E Van Schil
Journal:  J Thorac Dis       Date:  2016-10       Impact factor: 2.895

7.  Tiny lung adenocarcinomas: better prognosis with a word of caution.

Authors:  Ramón Rami-Porta
Journal:  J Thorac Dis       Date:  2016-09       Impact factor: 2.895

8.  Lobectomy: no port at all?

Authors:  Yanping Ren; Yuxin Jiao; Xiangpeng Zheng
Journal:  Ann Transl Med       Date:  2017-05

9.  Natural history of pathologically confirmed pulmonary subsolid nodules with deep learning-assisted nodule segmentation.

Authors:  Lin-Lin Qi; Jian-Wei Wang; Lin Yang; Yao Huang; Shi-Jun Zhao; Wei Tang; Yu-Jing Jin; Ze-Wei Zhang; Zhen Zhou; Yi-Zhou Yu; Yi-Zhou Wang; Ning Wu
Journal:  Eur Radiol       Date:  2020-11-21       Impact factor: 5.315

Review 10.  The importance of the regimen of screening in maximizing the benefit and minimizing the harms.

Authors:  Claudia I Henschke; Kunwei Li; Rowena Yip; Mary Salvatore; David F Yankelevitz
Journal:  Ann Transl Med       Date:  2016-04
View more

北京卡尤迪生物科技股份有限公司 © 2022-2023.